| | Editorial Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension Vasc Health Risk Manag. 2007 December; 3(6): 783–795. PMCID: PMC2350144 Reviews A review of nateglinide in the management of patients with type 2 diabetes Nicholas Tentolouris, Christina Voulgari, and Nicholas Katsilambros Vasc Health Risk Manag. 2007 December; 3(6): 797–807. PMCID: PMC2350129 Aliskiren – an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension Kristina Allikmets Vasc Health Risk Manag. 2007 December; 3(6): 809–815. PMCID: PMC2350136 Obesity management: Update on orlistat Belinda S Drew, Andrew F Dixon, and John B Dixon Vasc Health Risk Manag. 2007 December; 3(6): 817–821. PMCID: PMC2350121 Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications Brian C Cumbie and Kathie L Hermayer Vasc Health Risk Manag. 2007 December; 3(6): 823–832. PMCID: PMC2350125 Review of duloxetine in the management of diabetic peripheral neuropathic pain Timothy Smith and Robert A Nicholson Vasc Health Risk Manag. 2007 December; 3(6): 833–844. PMCID: PMC2350145 Atherogenic lipid profiles and its management in patients with rheumatoid arthritis Michael T Nurmohamed Vasc Health Risk Manag. 2007 December; 3(6): 845–852. PMCID: PMC2350142 Endothelial dysfunction in diabetes mellitus Hadi AR Hadi and Jassim Al Suwaidi Vasc Health Risk Manag. 2007 December; 3(6): 853–876. PMCID: PMC2350146 Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date Antonio Gaddi, AFG Cicero, FO Odoo, A Poli A, R Paoletti, and On behalf of the Atherosclerosis and Metabolic Diseases Study Group Vasc Health Risk Manag. 2007 December; 3(6): 877–886. PMCID: PMC2350131 Review of bosentan in the management of pulmonary arterial hypertension Eli Gabbay, John Fraser, and Keith McNeil Vasc Health Risk Manag. 2007 December; 3(6): 887–900. PMCID: PMC2350123 Clinical trial update: focus on the ONTARGET study David Fitchett Vasc Health Risk Manag. 2007 December; 3(6): 901–908. PMCID: PMC2350133 A review of the safety and efficacy of nebivolol in the mildly hypertensive patient Cockcroft John Vasc Health Risk Manag. 2007 December; 3(6): 909–917. PMCID: PMC2350132 Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes Nazia Raja-Khan, Sarah S Warehime, and Robert A Gabbay Vasc Health Risk Manag. 2007 December; 3(6): 919–935. PMCID: PMC2350128 Regulation of the renin–angiotensin system in coronary atherosclerosis: A review of the literature Ramadan A Hammoud, Christopher S Vaccari, Sameer H Nagamia, and Bobby V Khan Vasc Health Risk Manag. 2007 December; 3(6): 937–945. PMCID: PMC2350139 Inhaled insulin for controlling blood glucose in patients with diabetes Bernard L Silverman, Christopher J Barnes, Barbara N Campaigne, and Douglas B Muchmore Vasc Health Risk Manag. 2007 December; 3(6): 947–958. PMCID: PMC2350138 The applicability of home blood pressure measurement in clinical practice: A review of literature Willem J Verberk, Abraham A Kroon, Heidi A Jongen-Vancraybex, and Peter W de Leeuw Vasc Health Risk Manag. 2007 December; 3(6): 959–966. PMCID: PMC2350150 A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications Molavi Behzad, Rassouli Negah, Bagwe Suveer, and Rasouli Neda Vasc Health Risk Manag. 2007 December; 3(6): 967–973. PMCID: PMC2350137 Reduction of C-reactive protein and the use of anti-hypertensives Carmine Savoia and Ernesto L Schiffrin Vasc Health Risk Manag. 2007 December; 3(6): 975–983. PMCID: PMC2350124 Rationale for multiple risk intervention: The need to move from theory to practice Leif R Erhardt Vasc Health Risk Manag. 2007 December; 3(6): 985–997. PMCID: PMC2350141 Original Research A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice Maddalena Veronesi, Arrigo FG Cicero, Maria Grazia Prandin, Ada Dormi, Eugenio Cosentino, Enrico Strocchi, and Claudio Borghi Vasc Health Risk Manag. 2007 December; 3(6): 999–1005. PMCID: PMC2350135 Rheumatic heart disease: 15 years of clinical and immunological follow-up Roney O Sampaio, Kellen C Fae, Lea MF Demarchi, Pablo MA Pomerantzeff, Vera D Aiello, Guilherme S Spina, Ana C Tanaka, Sandra E Oshiro, Max Grinberg, Jorge Kalil, and Luiza Guilherme Vasc Health Risk Manag. 2007 December; 3(6): 1007–1017. PMCID: PMC2350126 Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease Mohammed Al-Omran Vasc Health Risk Manag. 2007 December; 3(6): 1019–1027. PMCID: PMC2350143 Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy John M Flack, Karl Duncan, Suzanne E Ohmit, Ruth Quah, Xuefeng Liu, Preeti Ramappa, Sandra Norris, Lowell Hedquist, Amanda Dudley, and Samar A Nasser Vasc Health Risk Manag. 2007 December; 3(6): 1029–1037. PMCID: PMC2350134 Higher persistence with valsartan compared with enalapril in daily practice Satu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, Zeba M Khan, Joëlle A Erkens, and Ron MC Herings Vasc Health Risk Manag. 2007 December; 3(6): 1039–1044. PMCID: PMC2350122 Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction Lena Björck, Catharina Welin, and Annika Rosengren Vasc Health Risk Manag. 2007 December; 3(6): 1045–1051. PMCID: PMC2350148 Pathogenic role of cardiac mast cell activation/degranulation, TNF-α, and cell death in acute drug-related fatalities Nasrin Perskvist, Carl Söderberg, Marianne van Hage, and Erik Edston Vasc Health Risk Manag. 2007 December; 3(6): 1053–1062. PMCID: PMC2350147 Adult nontwin sib concordance rates for type 2 diabetes, hypertension and metabolic syndrome among Asian Indians: The Indian Atherosclerosis Research Study Jayashree Shanker, Saikat Kanjilal, Veena S Rao, Ganapathy Perumal, Natesha B Khadrinarasimhiah, Manjari Mukherjee, Shamanna S Iyengar, and Vijay V Kakkar Vasc Health Risk Manag. 2007 December; 3(6): 1063–1068. PMCID: PMC2350127 Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity Barbara Ludolph, Wilhelm Bloch, Malte Kelm, Rainer Schulz, and Petra Kleinbongard Vasc Health Risk Manag. 2007 December; 3(6): 1069–1073. PMCID: PMC2350149 Acute management of poor condition subarachnoid hemorrhage patients Archavlis Eleftherios and Mario Nazareno Carvi y Nievas Vasc Health Risk Manag. 2007 December; 3(6): 1075–1082. PMCID: PMC2350130 Case Report Isolated periaortitis: Clinical and imaging characteristics Abdel-Rauf Zeina, Slobodin Gleb, Jochanan E Naschitz, Zeev Loberman, and Elisha Barmeir Vasc Health Risk Manag. 2007 December; 3(6): 1083–1086. PMCID: PMC2350140 |